Your Watchlist is Waiting!

Submit your email and you're on your way to tracking the stocks that matter to you.

Already a member? Sign in here.

We will use your e-mail address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our privacy statement

My Watchlist

Add Stocks

Example: AAPL, NFLX, HAS

You Are Watching

Symbol Last Change
VVUS $2.65 -$0.07 (-2.6%) X
DOW 17,191 -195.84 (-1.1%) S&P 500 2,002 -27.39 (-1.3%) NASD 4,638 -43.50 (-0.9%)

Thanks for joining My Watchlist. You now have access to your Motley Fool special report. Start Now! .

Recent Articles


Contrave Scripts Continue Increases For Orexigen

January 27, 2015 by Seeking Alpha


Benzinga's Top #PreMarket Gainers

January 23, 2015 by Benzinga


The 52-Week Low Club for Thursday

January 22, 2015 by 247wallst


Vivus (VVUS) Weak On High Volume

January 21, 2015 by TheStreet


5 Obesity Stocks Investors Are Watching

January 14, 2015 by Benzinga


Vivus Gets New 10% Stakeholder: What To Watch For

January 12, 2015 by Seeking Alpha


Anticipated FDA Approval Eludes Enteromedics

January 05, 2015 by Seeking Alpha


The 52-Week Low Club for Tuesday

December 30, 2014 by 247wallst


Sell EnteroMedics And Step To The Sidelines

December 30, 2014 by Seeking Alpha


Stocks Hitting 52-Week Lows

December 30, 2014 by Benzinga


Vivus (VVUS) Is Weak On High Volume Today

December 30, 2014 by TheStreet


The 52-Week Low Club for Monday

December 29, 2014 by 247wallst


Is Vivus Headed Towards An Unfortunate Ending?

December 27, 2014 by Seeking Alpha


Contrave Prescriptions Still Rising In A Down Week

December 22, 2014 by Seeking Alpha

Show More Activity...